[1]
U. Testa, E. Pelosi, and G. Castelliu, “Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topic”, Ann Ist Super Sanità, vol. 57, no. 4, pp. 300-313, Dec. 2021.